Z-1109-2021 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-1109-2021 was initiated by Becton Dickinson & Company on Dec 23, 2020 and is designated Class II. Reason for recall: The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package integrity and potentially compromises sterility of the syringe. The recall status is terminated (terminated Nov 21, 2022). Affected quantity: 155,200 needles.

Recall details

Product Type
Devices
Report Date
Feb 24, 2021
Initiation Date
Dec 23, 2020
Termination Date
Nov 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
155,200 needles

Product description

BD Hypodermic Syringe 10 ml, eccentric tip. Catalog (Ref No.) 305482

Reason for recall

The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package integrity and potentially compromises sterility of the syringe.

Distribution pattern

Distribution US nationwide and Canada

Code information

Catalog (Ref No.) 305482 100/package UDI 00382903054824 Lot # 8142303 exp date 31-May-2023

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1109-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1109-2021. Report a data issue: hello@regdatalab.com.